
Dow Jones biotech giant Amgen stock is trying to break out past a new buy point ahead of the firm's Q3 earnings report.
Oops, something went wrong

Dow Jones biotech giant Amgen stock is trying to break out past a new buy point ahead of the firm's Q3 earnings report.